Jon Najarian Sees Unusual Activity In Vivus
February 23, 2012 at 12:52 PM EST
Jon Najarian saw unusual activity in Vivus before its announcement Thursday regarding FDA approval.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.